Theses›Healthcare & bio›Diagnostics and health sensing

Diagnostics and health sensing

Liquid biopsies, real-time sensors and GLP-1-class drugs do not reduce system-level healthcare cost, they migrate it from acute treatment of today's cheap-and-fast killers into a longer tail of frailty, dementia and chronic disease

  • Early

The call, a draftLiquid biopsies, real-time sensors and GLP-1 drugs look more likely to move healthcare cost into longer chronic care than to cut it. The window is early, and the evidence on healthy years versus frail years has not come in.

D1D2D3R1R2C1foragainst D1D2D3R1R2C1foragainst
Fig. 1The balance. Drivers and catalysts against restraints, each block sized by its weight; catalysts hang dashed because they have not happened yet, sized by their odds. It tips toward the drivers.
  1. D1Liquid biopsies, real-time sensors, GLP-1 drugs and respiratory-disease prevention all cut deaths from heart attack, cancer and metabolic disease.
  2. D2Ageing and shrinking populations lengthen the tail of frailty, dementia and pension liability that survivors move into.
  3. D3Long-term care software grows from $4.71B in 2023 to about $8.21B by 2030, at about 8% a year.
  4. R1If GLP-1 drugs and early detection compress illness into fewer late years, the cheaper-healthcare story partly holds.
  5. R2There is no dated test and no system-level data yet showing acute spend falling while chronic and pension costs rise.
  6. C1Long-term care software reaches about $8.21B a year on Grand View's forecast.31 Dec 2030
Rests onthe beliefs underneath
Supported by · confidence
What would prove itdated tests, open and resolved
20272028202920302031today12watch 20272028202920302031today12watch
Fig. 2Each ring is a dated test: dashed while open, struck through when overdue, ticked or crossed once resolved.
  1. 1Long-term care software against about $8.21B a year.Dec 2030 · open
  2. 2Actuarial software for longevity and annuity pricing against about $860M a year.Dec 2030 · open
Expressionslisted, private, technologies
Technologies